Abstract Details

Title Development of Neurosarcoidosis during Exposure to Anti-TNF-Alpha Medications for Rheumatoid Arthritis: Case Report

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 198

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Daniel M. Harrison, MD, FAAN (University of Maryland School of Medicine)	Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Carlos A. Pardo-Villamizar, MD (Johns Hopkins U, Med Dept of Neurology)	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
	No disclosure on file

��ɫ��